Upcoming valuation, page-15

December 4. TheStreet's David Peltier on Investing in Stocks under $10 said this about Unilife: 'we'd consider adding to our position on the next market pullback, as we believe management is ramping up production and will continue to announce new pharmaceutical partnerships in the new year. UNIS Is a Game Breaker stock and has a price target of $6.50.'

That opinion coupled with Astra Zeneca (2,500,000) and Camber's (2,750,000) new positions saw me picking up shares today. Camber has affiliations with J.P. Morgan and Morgan Stanley. Hopefully the big money knows what's going on behind the scenes.

Kingsman,you old fox, good to see you like Kostya, a true champion of boxing.